Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study

Mie Klessen Eickhoff; Flemming Javier Olsen; Marie Frimodt-Møller; Lars Jorge Diaz; Jens Oscar Faber; Magnus Thorsten Jensen; Peter Rossing; Frederik Persson

Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study

Mie Klessen Eickhoff, Flemming Javier Olsen, Marie Frimodt-Møller, Lars Jorge Diaz, Jens Oscar Faber, Magnus Thorsten Jensen, Peter Rossing, Frederik Persson

Original language	English
Article number	SA-PO139
Journal	Journal of the American Society of Nephrology
Pages (from-to)	770
Number of pages	1
ISSN	1046-6673
Publication status	Published - 27 Oct 2018
Event	ASN, Kidney Week, San Diego, US - San Diego, United States Duration: 25 Oct 2018 → 28 Oct 2018

Conference

Conference	ASN, Kidney Week, San Diego, US
Country/Territory	United States
City	San Diego
Period	25/10/2018 → 28/10/2018

Access to Document

https://www.asn-online.org/api/download/?file=/education/kidneyweek/archives/KW18Abstracts.pdf

Cite this

Eickhoff, M. K., Olsen, F. J., Frimodt-Møller, M., Diaz, L. J., Faber, J. O., Jensen, M. T., Rossing, P., & Persson, F. (2018). Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study. Journal of the American Society of Nephrology, 770. Article SA-PO139. https://www.asn-online.org/api/download/?file=/education/kidneyweek/archives/KW18Abstracts.pdf

Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study. / Eickhoff, Mie Klessen; Olsen, Flemming Javier ; Frimodt-Møller, Marie et al.
In: Journal of the American Society of Nephrology, 27.10.2018, p. 770.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Eickhoff, MK, Olsen, FJ , Frimodt-Møller, M, Diaz, LJ, Faber, JO, Jensen, MT , Rossing, P & Persson, F 2018, 'Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study', Journal of the American Society of Nephrology, pp. 770. <https://www.asn-online.org/api/download/?file=/education/kidneyweek/archives/KW18Abstracts.pdf>

@article{d4d8c533b2ca4190aca23b2b83a3b888,

title = "Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study",

author = "Eickhoff, \{Mie Klessen\} and Olsen, \{Flemming Javier\} and Marie Frimodt-M{\o}ller and Diaz, \{Lars Jorge\} and Faber, \{Jens Oscar\} and Jensen, \{Magnus Thorsten\} and Peter Rossing and Frederik Persson",

year = "2018",

month = oct,

day = "27",

language = "English",

pages = "770",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "The American Society of Nephrology",

note = "ASN, Kidney Week, San Diego, US ; Conference date: 25-10-2018 Through 28-10-2018",

}

TY - ABST

T1 - Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study

AU - Eickhoff, Mie Klessen

AU - Olsen, Flemming Javier

AU - Frimodt-Møller, Marie

AU - Diaz, Lars Jorge

AU - Faber, Jens Oscar

AU - Jensen, Magnus Thorsten

AU - Rossing, Peter

AU - Persson, Frederik

PY - 2018/10/27

Y1 - 2018/10/27

M3 - Conference abstract in journal

SN - 1046-6673

SP - 770

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

M1 - SA-PO139

T2 - ASN, Kidney Week, San Diego, US

Y2 - 25 October 2018 through 28 October 2018

ER -